Insulin-like growth factor-I liposomal gene transfer and systemic growth hormone stimulate wound healing

Journal of Burn Care and Rehabilitation

Volumn 18, Issue 4, 1997, Pages 287-291

  Pierre, E J ^a   Perez Polo, J Regino ^a   Mitchell, Alfred T ^a   Matin, Sina ^a   Foyt, Howard L ^a   Herndon, David N ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCAGON; GROWTH HORMONE; HYDROCORTISONE; NORADRENALIN; SOMATOMEDIN C;

ARTICLE; BURN; EPITHELIZATION; GENE TRANSFER; GROWTH HORMONE BLOOD LEVEL; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTHESIS; WOUND HEALING;

EID: 0030795326     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199707000-00002     Document Type: Article

References (27)

1. Hill GL. Body composition research: implications for the practice of clinical nutrition. JPEN 1992;16:197-218.
2. Waterlow JC, Golden M, Picou D. The measurement of rates of protein turnover, synthesis, and breakdown in man and the effects of nutritional status and surgical injury. Am J Clin Nutr 1977;30:1333-9.
3. Shaw JHS, Wildbore M, Wolfe RR. Whole body protein kinetics in severely septic patients: the response to glucose infusion and total parenteral nutrition. Ann Surg 1986;295:288-94.
4. Streat SJ, Beddoe AH, Graham LH. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1984;27:262-6.
5. Ward HC, Halliday D, Sim AJW. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987;206:56-61.
6. Guler HP, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin-like growth factor-I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci U S A 1990;85:4889-93.
7. Walker JL, Ginalska-Malinowska G, Romer TE, Pucilowska JB, Underwood LE. Effects of the infusion of insulin-like growth factor-I in a child with growth hormone insensitivity syndrome (Laron dwarfism). N Engl J Med 1991;324:1483-8.
8. Clemmons DR, Smith-Banks A, Underwood LE. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab 1992;75:234-8.
9. Kupler SR, Underwood LE, Baxter RC, Clemmons DR. Growth factor-I by use of both agents simultaneously. J Clin Invest 1993;91:391-6.
10. Fleming RYD, Rutan RL, Jahoor F, Barrow RE, Wolfe RR, Herndon DN. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma 1992;32:698-703.
11. Walker HL, Mason AD Jr. A standard animal burn. J Trauma 1968;8:1049-50.
12. Herndon DN, Captain MC, Wilmore DN, Mason AD Jr. Development and analysis of a small animal model simulating the human postburn hypermetabolic response. J Surg Res 1978;25:394-403.
13. Lo HC, Hinton PS, Peterson CA, Ney DM. Simultaneously treatment with IGF-I and GH additively increases anabolism in parenterally fed rats. Am Physiol Soc 1995;32:368-76.
14. Rutan RL, Broemeling DL, Barrow RE, Herndon DN. Cost effectiveness of rhGH therapy in pediatric patients [abstract]. Proc Am Burn Assoc 1994;26:89.
15. Underwood LE, Clemmons DR, Maes M, D'Ercole AJ, Ketelslergers JM. Regulation of somatomedin-C/insulin-like growth factor-I by nutrients. Horm Res 1986;24:166-76.
16. Dahn MS, Lange P, Jacobs LA. Insulin-like growth factor-I production is inhibited in human sepsis. Arch Surg 1988;123: 1409-14.
17. Hawker FH, Stewart PM, Baxter RC, Borkmann M, Caterson D, McWilliam DB. Relationship of somatomedin-C/insulin-like growth factor-I levels to conventional nutritional indices in critically ill patients. Crit Care Med 1987;15:732-6.
18. Schwander JC, Hauri C, Zapf J, Froesch ER. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status Endocrinology 1983;113:297-305.
19. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin-C: further evidence tor multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 1984;81:935-9.
20. Orlopwski CC, Chernausek SD. Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in the rat. Endocrinology 1988;123:44-9.
21. Hansson HA, Jennische E, Skottner A. Regenerating endothelial cells express insulin-like growth factor-I immunoreactivity after arterial injury. Cell Tissue Res 1987;250:499-505.
22. Jennische E, Skottner A, Hansson HA. Satellite cells express the trophic factor IGF-I in regenerating skeletal muscle. Acta Physiol Scand 1987;129:9-15.
23. Conover CA, Rosenfeld RG, Hintz RL. Hormonal control of the replication of human fetal fibroblasts: role of somatomedin-C/insulin-like growth factor-I. J Cell Physiol 1986;128: 47-54.
24. Misra P, Nickoloff B J, Morhenn VB, Hintz RL, Rosenfeld RG. Characterization of insulin-like growth factor-I/somatomedin-C receptors on human keratinocyte monolayers. J Invest Dermatol 1986;87:264-7.
25. Meyer NA, Barrow RE, Pierre E J, Herndon DN. Effects of growth hormone and insulin-like growth factor-I on burn wound healing: a dose response. Proc Am Burn Assoc 1995; 27. [In press.]
26. Zezulak KM, Green H. The generation of insulin-like growth factor-I sensitive cells by growth hormone action. Science 1986;233:551-3.
27. Strock LL, Singh H, Abdullah A, Miller JA, Herndon DN. The effect of insulin-like growth factor-I on postburn hypermetabolism. Surg 1990;108:161-4.